바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Next
e-Submission

Vol.69 No.3
Citation Share

Smoking Cessation

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2010, v.69 no.3, pp.153-162


& (2010). Smoking Cessation. Tuberculosis & Respiratory Diseases, 69(3), 153-162.
  • Downloaded
  • Viewed
PDF Download

Abstract

Smoking is the most important risk factor of many pulmonary diseases, including chronic obstructive pulmonary disease and lung cancer, cardiovascular disorders and other malignancies. Therefore, smoking cessation is a practical way to prevent and treat smoking-related diseases. Also, the clinicians who care the patients with smoking-related disease should pay attention to it. This article reviews briefly recent publications focused on the influence of smoking cessation in some smoking-related diseases and strategies to improve smoking cessation such as pharmacotherapy or systemic behavioral approach programs. In addition, it reviews personalized therapy based on gene typing for smoking cessation.

keywords
Smoking Cessation, Prevention and control, Drug therapy, Smoking Cessation, Prevention and control, Drug therapy

Reference

1.

1. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.

2.

2. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr.Mortality from smoking in developed countries, 1950-2000: indirect estimates from national vital statistics. 1st ed. Oxford: Oxford University Press; 1994.

3.

3. Alberg AJ, Samet JM. Epidemiology of lung cancer.Chest 2003;123 Suppl 1:21S-49S.

4.

4. Gerber Y, Rosen LJ, Goldbourt U, Benyamini Y, Drory Y; Israel Study Group on First Acute Myocardial Infarction.Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study. J Am Coll Cardiol 2009;54:2382-7.

5.

5. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction:meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44.

6.

6. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290:86-97.

7.

7. Burling TA, Singleton EG, Bigelow GE, Baile WF,Gottlieb SH. Smoking following myocardial infarction:a critical review of the literature. Health Psychol 1984;3:83-96.

8.

8. Lindström D, Sadr Azodi O, Wladis A, Tønnesen H,Linder S, Nåsell H, et al. Effects of a perioperative smoking cessation intervention on postoperative complications:a randomized trial. Ann Surg 2008;248:739-45.

9.

9. Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 2003;238:1-5.

10.

10. Møller AM, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002;359:114-7.

11.

11. Salize HJ, Merkel S, Reinhard I, Twardella D, Mann K,Brenner H. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.Arch Intern Med 2009;169:230-5.

12.

12. Myung SK, McDonnell DD, Kazinets G, Seo HG, Moskowitz JM. Effects of web- and computer-based smoking cessation programs: meta-analysis of randomized controlled trials. Arch Intern Med 2009;169:929-37.

13.

13. Linder JA, Rigotti NA, Schneider LI, Kelley JH, Brawarsky P, Haas JS. An electronic health record-based intervention to improve tobacco treatment in primary care:a cluster-randomized controlled trial. Arch Intern Med 2009;169:781-7.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy